How To Prevent Cancer Naturally

Why is it that if you’re unfortunate enough to get cancer, your only option is to see an oncologist who will almost certainly recommend radiation, surgery or chemotherapy drugs? One reason is that it’s all they know. Conventional doctors are only educated to use the tools of modern medical technology. But there’s another reason that’s very concerning… Chemotherapy drugs are making oncologists very, very rich. You see, most doctors will just write you a prescription for a drug. But not oncologists. They buy these drugs at wholesale prices then sell them to cancer patients at marked-up prices. They’re the only specialists in mainstream medicine that are allowed to profit directly from the sale of a drug. And they depend on that money. It’s estimated that selling chemo drugs makes up 2/3 of cancer doctors’ incomes! Now, I don’t want to say they’re all crooks. That’s a lot of money. And even good people with good intentions can be influenced by that kind of financial incentive. Natural Remedies for Cancer Exclusion of natural therapies is universal. If there are cancer doctors out there who recommend these remedies, I haven’t met them. Not a single one. In fact, if you’re a cancer patient, they’ll likely tell you to toss out any supplements you’re taking. When I see a patient with cancer, I often feel like it’s a war between me and their oncologist… with the patient stuck in ...
Source: Al Sears, MD Natural Remedies - Category: Complementary Medicine Authors: Tags: Cancer Source Type: news

Related Links:

Date: Thursday, 04 09, 2020; Speaker: Zeynup Gumus, Assistant Professor, Ichan School of Medicine at Mount Sinai; https://cbiit.webex.com/mw3300/mywebex/default.do?
Source: NIH Calendar of Events - Category: American Health Source Type: events
Publication date: 31 March 2020Source: Cell Reports, Volume 30, Issue 13Author(s): Yue Zhang, Guoping Liu, Teng Guo, Xiaoyi G. Liang, Heng Du, Lin Yang, Aparna Bhaduri, Xiaosu Li, Zhejun Xu, Zhuangzhi Zhang, Zhenmeiyu Li, Miao He, Jeremiah Tsyporin, Arnold R. Kriegstein, John L. Rubenstein, Zhengang Yang, Bin Chen
Source: Cell Reports - Category: Cytology Source Type: research
Publication date: Available online 31 March 2020Source: CellAuthor(s): Marcus Ruscetti, John P. Morris, Riccardo Mezzadra, James Russell, Josef Leibold, Paul B. Romesser, Janelle Simon, Amanda Kulick, Yu-jui Ho, Myles Fennell, Jinyang Li, Robert J. Norgard, John E. Wilkinson, Direna Alonso-Curbelo, Ramya Sridharan, Daniel A. Heller, Elisa de Stanchina, Ben Z. Stanger, Charles J. Sherr, Scott W. Lowe
Source: Cell - Category: Cytology Source Type: research
Publication date: Available online 31 March 2020Source: Clinica Chimica ActaAuthor(s): Andras Komaromy, Balazs Reider, Gabor Jarvas, Andras Guttman
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
Publication date: Available online 31 March 2020Source: Clinica Chimica ActaAuthor(s): Yueting Xiong, Chao Shi, Xiaohui Liu, Pengyuan Yang
Source: Clinica Chimica Acta - Category: Laboratory Medicine Source Type: research
Authors: Ahmadianpour MV, Mowla J, Sotoodehnejadnematalahi F, Raheb J Abstract Studies on the blood of patients with prostate cancer using Dynamic Light Scattering (DLS) and corona protein size changes have shown that this test is highly specific and sensitive, but this method has not been studied in Iran, and therefore this study intends to perform this procedure using gold nanoparticles in prostate cancer detection. Blood samples of 60 male subjects aged 40-90 years were collected from 20 healthy, 20 benign and 20 prostate cancer patients. Optical scattering changes were measured by the level of gold nanoparticle...
Source: Human Antibodies - Category: Biochemistry Tags: Hum Antibodies Source Type: research
Publication date: Available online 31 March 2020Source: LWTAuthor(s): Joon-Goo Lee, Dae-Won Kim, Youngjae Shin, Young-Jun Kim
Source: LWT Food Science and Technology - Category: Food Science Source Type: research
Conclusion: After the third relapse of HGSC, cytotoxic chemotherapy did not prolong survival but was associated with substantially increased healthcare costs. PMID: 32223298 [PubMed - as supplied by publisher]
Source: Journal of Comparative Effectiveness Research - Category: General Medicine Tags: J Comp Eff Res Source Type: research
CONCLUSION: Our results showed increased percentages of regulatory T cells in pediatric ALL patients despite chemotherapy, which might be compromising the anti-leukemic cellular immune response. PMID: 32224544 [PubMed - in process]
Source: Iranian Journal of Immunology - Category: Allergy & Immunology Tags: Iran J Immunol Source Type: research
CONCLUSION: Our results indicated that MSC-secretome had DPP-IV/CD26 and APN/CD13 activity. The DPP-IV/CD26 activity was decreased following stimulation of MSCs by toll-like receptor 4 agonist. Further studies are needed to reveal the possible contribution of DPP-IV/CD26 and APN/CD13 in the anti-inflammatory functions of MSC-CM. PMID: 32224540 [PubMed - in process]
Source: Iranian Journal of Immunology - Category: Allergy & Immunology Tags: Iran J Immunol Source Type: research
More News: Bile Duct Cancer | Black Pepper | Breast Cancer | Cancer | Cancer & Oncology | Chemotherapy | Cholangiocarcinoma | Colon Cancer | Colorectal Cancer | Complementary Medicine | Gastroenterology | Health | Helicobacter Pylori | Herbs | Lung Cancer | Mitochondria | Mitochondrial Disease | Prostate Cancer | Smallpox | Stem Cell Therapy | Stem Cells | Study